Alto Neuroscience Inc. (ANRO) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Alto Neuroscience Inc.

    NYSE: ANRO · Real-Time Price · USD
    3.89
    -0.04 (-1.02%)
    At close: Sep 12, 2025, 3:59 PM
    3.97
    2.13%
    After-hours: Sep 12, 2025, 06:00 PM EDT

    Alto Neuroscience Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a 210K
    Cost of Revenue
    		 502K 373K 342K 145K
    Gross Profit
    		 -502K -373K -342K 65K
    Operating Income
    		 -68.61M -37.81M -29.19M -12.06M
    Interest Income
    		 8.85M 2.35M 114K 2K
    Pretax Income
    		 -61.43M -36.3M -27.71M -9.19M
    Net Income
    		 -61.43M -36.3M -27.71M -9.19M
    Selling & General & Admin
    		 21.61M 7.52M 5.16M 3.75M
    Research & Development
    		 47M 30.29M 23.69M 8.37M
    Other Expenses
    		 -502K n/a n/a n/a
    Operating Expenses
    		 68.11M 37.81M 28.85M 12.12M
    Interest Expense
    		 -1.38M 1.37M n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a -342K -145K
    Cost & Expenses
    		 68.61M 37.81M 29.19M 12.27M
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 24.6M 26.88M 25.57M 25.57M
    Shares Outstanding (Diluted)
    		 24.6M 26.88M 25.57M 25.57M
    EPS (Basic)
    		 -2.5 -1.35 -1.08 -0.36
    EPS (Diluted)
    		 -2.5 -1.35 -1.08 -0.36
    EBITDA
    		 -68.61M -34.56M -27.37M -9.04M
    EBIT
    		 -62.81M -34.94M -27.71M -9.19M
    Depreciation & Amortization
    		 -5.8M 373K 342K 145K

    Add to Watchlist